Every dollar will be matched! Help fund the critical next phase of Islet Sheet research.
After years of research, we are close to realizing a dream for people with type 1: using the Islet Sheet to normalize blood sugar without immune suppression drugs. JDRF has recognized the promise of encapsulated islets and is funding tests of the Islet Sheet. But we need your help to speed this innovation to clinical trials. A generous donor will match every dollar up to $50,000!
June 14, 2013
This spring, Dr. Jonathan R. T. Lakey, a principal collaborator in the Islet Sheet Project, was awarded a major grant by JDRF (formerly the Juvenile Diabetes Research Foundation) to study... READ MORE
April 15, 2013
Over the weekend, Hanuman Medical Foundation received a very generous matching grant of $50,000 to encourage community-based funding for the Islet Sheet Project. This means Hanuman will begin an... READ MORE
There is still no cure for type 1 diabetes, despite decades of research and promises. Most people with the disease say that a “cure” should mean being able to live a healthy life, free of dependence on external insulin—and without using powerful drugs that suppress the body's immune response. Only one current line of research holds real hope for both in the near term: the therapy known as encapsulated islets or the bioartificial pancreas. Hanuman Medical Foundation supports this vital research through its work with the Islet Sheet Project, a long-term collaboration by a team of leading diabetes researchers and medical inventors.
The Islet Sheet Project expects to begin clinical trials in 2013. This can be life-changing news for people with type 1 diabetes and their loved ones. We're committed to real progress, not promises. Please read on … and join us.
“We believe this technology has significant potential to be considered a ‘cure’ for type 1 diabetes.”
—The authors of Targeting a Cure for Type 1 Diabetes
ASK AN EXPERT
Have a question about diabetes research, especially about islet transplantation? Looking for sound advice about managing type 1 diabetes? Interested in the work of our foundation? Ask here, and an expert from the Hanuman team will respond.
Hi Experts! I have what is probably a very basic question, so I thank you for your patience! In animal studies, as I understand it, the animals are "made diabetic" via a pancreatectomy. How reflective is this of the immune-mediated disease in humans? Or are there animal studies which use those animals whose diabetes is initiated via the immune system? As I said, I am sure this is a very basic question so please do not hesitate to simply post a link to where I can find the answer. Many thanks, and keep up the amazing work. You give me hope that I will one day be able to tell my son he will never have to inject himself again. Oh what a day that would be...
This is an excellent question, Amy, and reflects a serious problem in autoimmune diabetes research. We need good animal models for diabetes. A large animal such as a dog is best for metabolic studies. Pancreatectomy is excellent in making these animals... READ MORE
Watch a clip from the documentary film The Human Trial of Scott King describing how he was diagnosed with type 1. Learn more about the film.
This blog is most often authored by Scott R. King, president and founder of Islet Sheet Medical, a biotechnology company working with Hanuman Medical Foundation. Scott was diagnosed with type 1 diabetes in 1977, and since then has been devoted to understanding and ameliorating the disease. The Sheet shares updates on our work and welcomes comments.
February 25th, 2014
By John D. Golenski, Executive Director, Hanuman Medical Foundation Now and then this blog takes a break from reporting on developments with islet encapsulation and the Islet Sheet to report on someone living with type 1 diabetes. The end goal of our scientific quest is a practical cure for diabetes – but until then, we... READ MORE
February 19th, 2014
In this “reboot” series we review recent developments in encapsulated islet technology and what they mean for the future of the Islet Sheet Project. Today we look at the granddaddy of these projects, LCT’s DIABECELL for type 1 diabetes. DIABECELL was the first encapsulation technology to reach the clinic in a private setting, and consists... READ MORE
Animated views of how the Islet Sheet with its encapsulated islets works
Tweets by @ScottRobertKing